Form 8-K - Current report:
SEC Accession No. 0001683168-19-001520
Filing Date
2019-05-14
Accepted
2019-05-14 17:20:11
Documents
3
Period of Report
2019-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K phio_8k.htm 8-K 21098
2 PRESS RELEASE phio_ex-9901.htm EX-99.1 45157
3 GRAPHIC image_001.jpg GRAPHIC 2412
  Complete submission text file 0001683168-19-001520.txt   70960
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 19823924
SIC: 2834 Pharmaceutical Preparations